These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

226 related articles for article (PubMed ID: 25738895)

  • 21. Pyruvate into lactate and back: from the Warburg effect to symbiotic energy fuel exchange in cancer cells.
    Feron O
    Radiother Oncol; 2009 Sep; 92(3):329-33. PubMed ID: 19604589
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Dasatinib, a multi-kinase inhibitor increased radiation sensitivity by interfering with nuclear localization of epidermal growth factor receptor and by blocking DNA repair pathways.
    Raju U; Riesterer O; Wang ZQ; Molkentine DP; Molkentine JM; Johnson FM; Glisson B; Milas L; Ang KK
    Radiother Oncol; 2012 Nov; 105(2):241-9. PubMed ID: 23010482
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Crizotinib Fails to Enhance the Effect of Radiation in Head and Neck Squamous Cell Carcinoma Xenografts.
    Baschnagel AM; Galoforo S; Thibodeau BJ; Ahmed S; Nirmal S; Akervall J; Wilson GD
    Anticancer Res; 2015 Nov; 35(11):5973-82. PubMed ID: 26504020
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Enhancement of radiosensitivity in head and neck cancer cells by ZD1839 ('IRESSA'), a selective epidermal growth factor receptor tyrosine kinase inhibitor.
    Shintani S; Kiyota A; Mihara M; Sumida T; Kayahara H; Nakashiro K; Hamakawa H
    Am J Clin Oncol; 2003 Oct; 26(5):e150-6. PubMed ID: 14528090
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Energy metabolism of leukemia cells: glycolysis versus oxidative phosphorylation.
    Suganuma K; Miwa H; Imai N; Shikami M; Gotou M; Goto M; Mizuno S; Takahashi M; Yamamoto H; Hiramatsu A; Wakabayashi M; Watarai M; Hanamura I; Imamura A; Mihara H; Nitta M
    Leuk Lymphoma; 2010 Nov; 51(11):2112-9. PubMed ID: 20860495
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Overcoming radioresistance in head and neck squamous cell carcinoma.
    Yamamoto VN; Thylur DS; Bauschard M; Schmale I; Sinha UK
    Oral Oncol; 2016 Dec; 63():44-51. PubMed ID: 27938999
    [TBL] [Abstract][Full Text] [Related]  

  • 27. MTHFD2 Blockade Enhances the Efficacy of β-Lapachone Chemotherapy With Ionizing Radiation in Head and Neck Squamous Cell Cancer.
    Shukla K; Singh N; Lewis JE; Tsang AW; Boothman DA; Kemp ML; Furdui CM
    Front Oncol; 2020; 10():536377. PubMed ID: 33262939
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Fitter Mitochondria Are Associated With Radioresistance in Human Head and Neck SQD9 Cancer Cells.
    Grasso D; Medeiros HCD; Zampieri LX; Bol V; Danhier P; van Gisbergen MW; Bouzin C; Brusa D; Grégoire V; Smeets H; Stassen APM; Dubois LJ; Lambin P; Dutreix M; Sonveaux P
    Front Pharmacol; 2020; 11():263. PubMed ID: 32231567
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Acquired resistance to cetuximab is associated with the overexpression of Ras family members and the loss of radiosensitization in head and neck cancer cells.
    Saki M; Toulany M; Rodemann HP
    Radiother Oncol; 2013 Sep; 108(3):473-8. PubMed ID: 23891090
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Activation of mitochondrial oxidation by PDK2 inhibition reverses cisplatin resistance in head and neck cancer.
    Roh JL; Park JY; Kim EH; Jang HJ; Kwon M
    Cancer Lett; 2016 Feb; 371(1):20-9. PubMed ID: 26607904
    [TBL] [Abstract][Full Text] [Related]  

  • 31. IL-6 antisense-mediated growth inhibition in a head and neck squamous cell carcinoma cell line.
    Bran G; Götte K; Riedel K; Hörmann K; Riedel F
    In Vivo; 2011; 25(4):579-84. PubMed ID: 21708999
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cancer stem cells in head and neck squamous cell cancer.
    Prince ME; Ailles LE
    J Clin Oncol; 2008 Jun; 26(17):2871-5. PubMed ID: 18539966
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Acetyl-CoA carboxylase rewires cancer metabolism to allow cancer cells to survive inhibition of the Warburg effect by cetuximab.
    Luo J; Hong Y; Lu Y; Qiu S; Chaganty BK; Zhang L; Wang X; Li Q; Fan Z
    Cancer Lett; 2017 Jan; 384():39-49. PubMed ID: 27693630
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A 13-gene expression-based radioresistance score highlights the heterogeneity in the response to radiation therapy across HPV-negative HNSCC molecular subtypes.
    Foy JP; Bazire L; Ortiz-Cuaran S; Deneuve S; Kielbassa J; Thomas E; Viari A; Puisieux A; Goudot P; Bertolus C; Foray N; Kirova Y; Verrelle P; Saintigny P
    BMC Med; 2017 Sep; 15(1):165. PubMed ID: 28859688
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Protective role of Hsp27 protein against gamma radiation-induced apoptosis and radiosensitization effects of Hsp27 gene silencing in different human tumor cells.
    Aloy MT; Hadchity E; Bionda C; Diaz-Latoud C; Claude L; Rousson R; Arrigo AP; Rodriguez-Lafrasse C
    Int J Radiat Oncol Biol Phys; 2008 Feb; 70(2):543-53. PubMed ID: 17980509
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Tumor growth retardation and chemosensitizing action of fatty acid synthase inhibitor orlistat on T cell lymphoma: implication of reconstituted tumor microenvironment and multidrug resistance phenotype.
    Kant S; Kumar A; Singh SM
    Biochim Biophys Acta; 2014 Jan; 1840(1):294-302. PubMed ID: 24060750
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Differential expression of proteins in radioresistant and radiosensitive human squamous carcinoma cells.
    Ramsamooj P; Kasid U; Dritschilo A
    J Natl Cancer Inst; 1992 Apr; 84(8):622-8. PubMed ID: 1556773
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Growth inhibition and chemo-radiosensitization of head and neck squamous cell carcinoma (HNSCC) by survivin-siRNA lentivirus.
    Khan Z; Khan AA; Prasad GB; Khan N; Tiwari RP; Bisen PS
    Radiother Oncol; 2016 Feb; 118(2):359-68. PubMed ID: 26747757
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Afatinib radiosensitizes head and neck squamous cell carcinoma cells by targeting cancer stem cells.
    Macha MA; Rachagani S; Qazi AK; Jahan R; Gupta S; Patel A; Seshacharyulu P; Lin C; Li S; Wang S; Verma V; Kishida S; Kishida M; Nakamura N; Kibe T; Lydiatt WM; Smith RB; Ganti AK; Jones DT; Batra SK; Jain M
    Oncotarget; 2017 Mar; 8(13):20961-20973. PubMed ID: 28423495
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Targeting fatty acid synthase in breast and endometrial cancer: An alternative to selective estrogen receptor modulators?
    Lupu R; Menendez JA
    Endocrinology; 2006 Sep; 147(9):4056-66. PubMed ID: 16809439
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.